<DOC>
	<DOCNO>NCT00037297</DOCNO>
	<brief_summary>To locate identify gene contribute genetic component subclinical cardiovascular disease ( CVD ) Type 2 diabetes evaluate impact lifestyle environment expression genetic component subclinical CVD .</brief_summary>
	<brief_title>Epidemiology Cardiovascular Disease Diabetes</brief_title>
	<detailed_description>BACKGROUND : Atherosclerosis important complication diabetes reason accelerated course patient condition poorly understood . Diabetes increase prevalence exact heavy disease burden United States population come year . Secondary prevention atherosclerotic complication would great value . The rationale underlying genetic study new pathway could identify functional genomics . DESIGN NARRATIVE : The following hypothesis test : 1 ) The risk develop Type 2 diabetes-associated cardiovascular disease ( CVD ) significant heritable component measure , 2 ) The chromosomal location gene contribute CVD Type 2 diabetes determine gene identify use modern molecular genetic approach . The investigator predict genetic factor detect study sibling pair Type 2 diabetes genetic epidemiology method linkage analysis . Type 2 diabetes-affected sibling pair , unaffected sibling , parent , available , recruited multiple clinical subclinical measure subclinical CVD risk assess , include coronary artery calcification ( CAC ) , carotid arterial wall thickness ( IMT ) , ECG variable , prevalent CVD . Data patient collect one visit General Clinical Research Center ( GCRC ) include interview physical examination , rest 12-lead electrocardiogram ( ECG ) , B-mode ultrasound carotid artery , retrospectively gated helical CT ( RGHCT ) , spectrum clinical laboratory measure . Genetic epidemiological method use evaluate familial aggregation subclinical CVD take consideration effect share environmental exposure ( e.g . smoking , diet , alcohol intake physical activity ) clinical measure ( e.g. , body mass index , blood pressure , lipid , age , sex , etc. ) . Initial estimate heritability suggest significant heritable component subclinical CVD . Clinical evaluation follow comprehensive molecular genetic analysis sib pairs/families include genome wide screen , follow focused effort create high quality dataset regenotyping replace problem marker . Evidence linkage quantitative trait locus ( QTLs ) influence CAC IMT pursue chromosomal region show suggestive evidence linkage perform analysis detect association `` saturation '' marker .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>